Martin Pule Insider Profile

4 Followers
Martin Pule, Chief Scientific Officer at Autolus Therapeutics, holds ― shares in Autolus Therapeutics (Ticker: AUTL). Most recently, Martin Pule Sold $698,741 shares of Autolus Therapeutics on Sep 17, 2024 for an estimated value of 2.96M.
tipranks
Martin  Pule

Martin Pule
Autolus Therapeutics (AUTL)
Chief Scientific Officer

Not Ranked
Martin Pule has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Martin Pule does not currently own shares as a corporate insider.
A breakdown of Martin Pule's holdings

Insider Roles

Autolus Therapeutics
(AUTL)
Chief Scientific Officer
Roles that Martin Pule holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Martin Pule

Martin Pule's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Autolus Therapeutics
Sep 17, 2024
Chief Scientific Officer
Informative Sell
2.96M
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Sep 17, 2024
Informative Sell
$2.96M
-
$4.23
List of latest transactions for each holding click on a transaction to see Martin Pule's performance on stock

Martin Pule insider profile FAQ

What is the percentage of profitable transactions made by Martin Pule?
The percentage of profitable transactions made by Martin Pule is ―.
    What is the average return per transaction made by Martin Pule?
    The average return per transaction made by Martin Pule is ―.
      What stocks does Martin Pule hold?
      Martin Pule holds: AUTL stocks.
        What was Martin Pule’s latest transaction?
        Martin Pule latest transaction was an Informative Sell of $2.96M.
          What was Martin Pule's most profitable transaction?
          Martin Pule’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Martin Pule's role in Autolus Therapeutics?
            Martin Pule's role in Autolus Therapeutics is Chief Scientific Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.